| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President and CEO | President, CEO and CFO
1 company
William Tai-Wei Ho is President and CEO at INAB. William Tai-Wei Ho's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $115K at current prices.
Net of sales, the INAB filings show accumulation of 50,115 shares.
William Tai-Wei Ho has 18 Form 4 filings on record from July 2021 to May 2026, all as CEO at IN8bio (INAB), 2021–2026.
The 26 reported transactions were 17 option or other derivative awards, 3 stock awards, 3 dispositions back to the company and 2 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $75K and no sales.
The largest open-market purchase was 26,315 shares of INAB at an average $1.90 on August 16, 2022, about $50K. Twelve months later INAB was down 37%.